Page last updated: 2024-09-04
pralnacasan and sulfathiazole
pralnacasan has been researched along with sulfathiazole in 2 studies
Compound Research Comparison
Studies (pralnacasan) | Trials (pralnacasan) | Recent Studies (post-2010) (pralnacasan) | Studies (sulfathiazole) | Trials (sulfathiazole) | Recent Studies (post-2010) (sulfathiazole) |
---|---|---|---|---|---|
19 | 0 | 7 | 656 | 4 | 89 |
Protein Interaction Comparison
Protein | Taxonomy | pralnacasan (IC50) | sulfathiazole (IC50) |
---|---|---|---|
Dihydropteroate synthase | Escherichia coli K-12 | 2.5 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 2.5 | |
Transcriptional activator protein LasR | Pseudomonas aeruginosa PAO1 | 9 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Reviews
1 review(s) available for pralnacasan and sulfathiazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
1 other study(ies) available for pralnacasan and sulfathiazole
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |